A Case Report on Zoledronic Acid as Palliative Treatment in Carcinoma of Lung with Bone Metastasis
Bone metastasis is a general complication of advanced carcinomas, usually seen in breast cancer, prostate cancer, non-small cell lung cancer and multiple myeloma. Zoledronic acid, which belongs to bisphosphonates, is indicated for bone metastasis caused due to carcinomas. This case report is about a...
Main Authors: | Sandhya Y., Swathi M., Yeshavanth G., Nagaraja V.T. |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2023-07-01
|
Series: | Forum of Clinical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.2478/fco-2023-0001 |
Similar Items
-
Management of bone metastasis with zoledronic acid: A systematic review and Bayesian network meta-analysis
by: Justin-Pierre Lorange, et al.
Published: (2023-04-01) -
Comparison of denosumab and zoledronic acid for the treatment of solid tumors and multiple myeloma with bone metastasis: a systematic review and meta-analysis based on randomized controlled trials
by: Lianghai Jiang, et al.
Published: (2021-06-01) -
Evaluation of zoledronate for the treatment of canine stage III osteosarcoma: A phase II study
by: Ashley A. Smith, et al.
Published: (2023-01-01) -
Radiolabeling and Biological Evaluation of 153Sm and 175Yb Zoledronic Acid Complexes
by: A.R Jalilian, et al.
Published: (2016-05-01) -
Effect of Systemic Zoledronic Acid Dosing Regimens on Bone Regeneration in Osteoporotic Rats
by: Marwa Y. Shaheen, et al.
Published: (2021-02-01)